Markus Haass

7.0k citations
152 papers · 5.3k · 2 hit papers · h-index 37

Impact in

Papers in

    • Heart Failure Treatment and Management 43
    • Cardiac electrophysiology and arrhythmias 12
    • Acute Myocardial Infarction Research 10
    • Cardiac Health and Mental Health 9
    • Cardiovascular Function and Risk Factors 9
    • Receptor Mechanisms and Signaling 28
    • Ion channel regulation and function 15

Markus Haass

147 papers receiving 5.1k citations

Markus Haass's Hit Papers

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial 2021 · 235 citations
2350+2+4Years since publication50100150200250

Peers

Markus Haass
Comparison fields: 5 of 122
  • Cardiology and Cardiovascular Medicine 2.8k
  • Complementary and alternative medicine 295
  • Endocrinology, Diabetes and Metabolism 499
  • Cellular and Molecular Neuroscience 528
  • Behavioral Neuroscience 85
Replace M. Gary Nicholls with:
M. Gary Nicholls New Zealand
T. Barry Levine United States
Teruo Omae Japan
Gert A. van Montfrans Netherlands
Junichiro Hashimoto Japan
Steven R. Goldsmith United States
Masahiro Kohzuki Japan
Leonard Arnolda Australia
Dirk L. Brutsaert Belgium
Theo Thien Netherlands
Markus Haass relative to M. Gary Nicholls New Zealand M. Gary Nicholls's profile →
Citations per field
00.5×5.3×
M. Gary Nicholls · 1×
Citations per year

Countries citing papers authored by Markus Haass

Since Specialization
Citations

This map shows the geographic impact of Markus Haass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Haass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Haass more than expected).

Fields of papers citing papers by Markus Haass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Haass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Haass. The network helps show where Markus Haass may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Haass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Haass Line = papers co-authored together Markus Haass links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction
Hit paper breakdown →
2020285
2 2011270
3 2010259
4
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
Hit paper breakdown →
2021235
5 1997232
6 2001222
7 2010195
8 2016191
9 2004178
10 2002163
11 1986141
12 1991124
13 2001111
14 2019103
15 2002101
16 200197
17 201490
18 198684
19 200674
20 201571

About Markus Haass

Markus Haass is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Cellular and Molecular Neuroscience, Surgery and Pulmonary and Respiratory Medicine, having authored 152 papers that have together received 5.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (43 papers), Receptor Mechanisms and Signaling (28 papers), Neuropeptides and Animal Physiology (24 papers), Ion channel regulation and function (15 papers), Cardiac electrophysiology and arrhythmias (12 papers), Acute Myocardial Infarction Research (10 papers), Cardiac Health and Mental Health (9 papers) and Cardiovascular Function and Risk Factors (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.8k citations), Complementary and alternative medicine (295 citations), Endocrinology, Diabetes and Metabolism (499 citations), Cellular and Molecular Neuroscience (528 citations) and Behavioral Neuroscience (85 citations). Markus Haass has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christian Zugck, Zofia Żukowska-Grójec, Alan B. Miller, Peter E. Carson, W. Kübler, Inder S. Anand, Dieter Schellberg, Gert Richardt, Armin Haunstetter and Albert Schömig. Their work appears in journals such as Journal of the American College of Cardiology, Journal of Molecular and Cellular Cardiology, Naunyn-Schmiedeberg s Archives of Pharmacology, Circulation and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact